{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT03036124_ADAURA\\NCT03036124_ADAURA_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Full Analysis Set",
        "text": "All patients who have been randomized to study treatment will be included in the full analysis set (FAS) irrespective of their protocol adherence and continued participation in the study. Patients will be analysed according to their randomized IP assignment, irrespective of the treatment actually received.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "populationDescription": "All patients who have been randomized to study treatment will be included in the full analysis set (FAS) irrespective of their protocol adherence and continued participation in the study. Patients will be analysed according to their randomized IP assignment, irrespective of the treatment actually received.",
        "criteria": "All randomized patients"
      },
      {
        "id": "pop_2",
        "name": "Safety Analysis Set",
        "text": "All randomized patients who received at least one dose of study treatment. Patients will be analysed according to the treatment actually received.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "populationDescription": "All randomized patients who received at least one dose of study treatment. Patients will be analysed according to the treatment actually received.",
        "criteria": "Randomized AND received >=1 dose of study treatment"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Type 2 diabetes (T2D) status",
        "code": "TYPE_2_DIABETES_(T2D",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Type 2 diabetes (T2D) status",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Established diagnosis of T2D or HbA1c more or equal to 6.5% (48 mmol/mol) shown at central laboratory test at enrolment"
      },
      {
        "id": "char_2",
        "name": "LVEF category",
        "code": "LVEF_CATEGORY",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "LVEF category",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Left ventricular ejection fraction category"
      },
      {
        "id": "char_3",
        "name": "NYHA class",
        "code": "NYHA_CLASS",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "NYHA class",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "New York Heart Association functional classification"
      }
    ],
    "summary": {
      "populationCount": 2,
      "characteristicCount": 3
    }
  }
}